Valemetostat: First approval as a dual inhibitor of EZH1/2 to treat adult T-cell leukemia/lymphoma

Dou, FZ; Tian, ZX; Yang, X; Li, J; Wang, RQ; Gao, JJ

Gao, JJ (通讯作者)，Qingdao Univ, Sch Pharm, Dept Pharmacol, Qingdao, Shandong, Peoples R China.

DRUG DISCOVERIES AND THERAPEUTICS, 2022; 16 (6): 297

Abstract

Adult T-cell leukemia/lymphoma (ATL) is a mature T-cell lymphoma with a poor prognosis. Accumulating trimethylation of histone H3 lysine 27 (H3K27me3)......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索